They haven't decreased the price, they're just doing exactly what Howie said Botanix are going to do and aggressively buying down co-pays, Qbrexza, as SB will be, is tier 3 on all insurer lists i've seen. This means it's the highest co-pay, which depending on the quality of the insurer can mean patient payments of over $200. Journey are essentially discounting by the level of co-pay which is why these calculations people are coming up with based on $600 or $700 a month are just nonsense.
Bot Chart, page-7333
-
- There are more pages in this discussion • 8,558 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
-0.005(1.47%) |
Mkt cap ! $608.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.3¢ | 32.5¢ | $1.200M | 3.588M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 349093 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 25403 | 5 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |